Aminoglycoside and its derivatives as ligands to target the ribosome
- PMID: 12678834
- DOI: 10.2174/1568026033452131
Aminoglycoside and its derivatives as ligands to target the ribosome
Abstract
Protein synthesis is a central function in cellular physiology, and this important process is the target of many naturally occurring antibiotics and toxins. One such antibiotic is the aminoglycoside, which has been widely utilized in the clinical in the last fifty years due to their low cost and reliable activities. However the usage and applications of aminoglycosides have been severely limited due to their numerous side effects and resistance mechanism acquired by bacteria. Advances in understanding their mechanism of action have led to attempts in developing novel aminoglycoside-derivatives that would potentially eliminate harmful side effects and be resistant to aminoglycoside-modifying enzymes. This account provides a brief introduction to the various classes of antibiotics that target the ribosome, and also provide highlights in recent advancement of the synthesis of aminoglycoside analogs.
Similar articles
-
Modification at the 2'-Position of the 4,5-Series of 2-Deoxystreptamine Aminoglycoside Antibiotics To Resist Aminoglycoside Modifying Enzymes and Increase Ribosomal Target Selectivity.ACS Infect Dis. 2019 Oct 11;5(10):1718-1730. doi: 10.1021/acsinfecdis.9b00128. Epub 2019 Sep 13. ACS Infect Dis. 2019. PMID: 31436080 Free PMC article.
-
Aminoglycosides versus bacteria--a description of the action, resistance mechanism, and nosocomial battleground.J Biomed Sci. 2008 Jan;15(1):5-14. doi: 10.1007/s11373-007-9194-y. Epub 2007 Jul 27. J Biomed Sci. 2008. PMID: 17657587 Review.
-
Ribosome-targeting antibiotics and mechanisms of bacterial resistance.Nat Rev Microbiol. 2014 Jan;12(1):35-48. doi: 10.1038/nrmicro3155. Nat Rev Microbiol. 2014. PMID: 24336183 Review.
-
Mechanistic Insights into Clinically Relevant Ribosome-Targeting Antibiotics.Biomolecules. 2024 Oct 7;14(10):1263. doi: 10.3390/biom14101263. Biomolecules. 2024. PMID: 39456196 Free PMC article. Review.
-
Detection and Quantification of Ribosome Inhibition by Aminoglycoside Antibiotics in Living Bacteria Using an Orthogonal Ribosome-Controlled Fluorescent Reporter.ACS Chem Biol. 2016 Jan 15;11(1):31-7. doi: 10.1021/acschembio.5b00779. Epub 2015 Nov 4. ACS Chem Biol. 2016. PMID: 26514081 Free PMC article.
Cited by
-
Mitochondrial optic neuropathies - disease mechanisms and therapeutic strategies.Prog Retin Eye Res. 2011 Mar;30(2):81-114. doi: 10.1016/j.preteyeres.2010.11.002. Epub 2010 Nov 26. Prog Retin Eye Res. 2011. PMID: 21112411 Free PMC article. Review.
-
Cystic fibrosis transmembrane conductance regulator protein repair as a therapeutic strategy in cystic fibrosis.Curr Opin Pulm Med. 2010 Nov;16(6):591-7. doi: 10.1097/MCP.0b013e32833f1d00. Curr Opin Pulm Med. 2010. PMID: 20829696 Free PMC article. Review.
-
Assessing specific oligonucleotides and small molecule antibiotics for the ability to inhibit the CRD-BP-CD44 RNA interaction.PLoS One. 2014 Mar 12;9(3):e91585. doi: 10.1371/journal.pone.0091585. eCollection 2014. PLoS One. 2014. PMID: 24622399 Free PMC article.
-
The use of aminoglycoside derivatives to study the mechanism of aminoglycoside 6'-N-acetyltransferase and the role of 6'-NH2 in antibacterial activity.Bioorg Med Chem. 2007 Apr 15;15(8):2944-51. doi: 10.1016/j.bmc.2007.02.009. Epub 2007 Feb 11. Bioorg Med Chem. 2007. PMID: 17317190 Free PMC article.
-
Restoration of W1282X CFTR activity by enhanced expression.Am J Respir Cell Mol Biol. 2007 Sep;37(3):347-56. doi: 10.1165/rcmb.2006-0176OC. Epub 2007 May 31. Am J Respir Cell Mol Biol. 2007. PMID: 17541014 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical